Hemoglobin News and Research

RSS

Adults with Type 2 diabetes achieve better blood glucose control after sleeve gastrectomy surgery

Adults with Type 2 diabetes achieve better blood glucose (sugar) control two years after undergoing laparoscopic sleeve gastrectomy than do patients who receive standard medical diabetes care without this weight loss surgery, a new study finds.

23 Jun 2014

Soy protein supplements do not reduce testosterone levels in men with Type 2 diabetes

Soy protein supplements, which contain natural estrogens, do not reduce testosterone levels in men with Type 2 diabetes who already have borderline-low testosterone, according to a new study.

23 Jun 2014

Researchers find possible biological reason why people with diabetes are prone to depression

Researchers have found a possible biological reason why people with diabetes are prone to depression.

23 Jun 2014

Empagliflozin lowers blood pressure in patients with Type 2 diabetes and hypertension

An investigational drug to treat Type 2 diabetes, empagliflozin, lowers blood pressure in patients with Type 2 diabetes and hypertension (high blood pressure), a new study finds.

23 Jun 2014

Empagliflozin drug reduces blood pressure in patients with Type 2 diabetes, hypertension

An investigational drug to treat Type 2 diabetes, empagliflozin, lowers blood pressure in patients with Type 2 diabetes and hypertension (high blood pressure), a new study finds. The results were presented Sunday in a late-breaking abstract at the joint meeting of the International Society of Endocrinology and The Endocrine Society: ICE/ENDO 2014 in Chicago.

23 Jun 2014

Five specific tests commonly performed in anesthesiology may not be necessary

Proving that less really is more, five specific tests or procedures commonly performed in anesthesiology that may not be necessary and, in some cases should be avoided, will be published online June 16 in JAMA Internal Medicine.

17 Jun 2014

Six essential screening tests all men should receive during lifetime

When it's comes men and health, the numbers don't stack up. Compared to women, men are 24 percent less likely than women to visit the doctor, according to the U.S. Department of Health & Human Services. Yet, men are 28 percent more likely than women to be hospitalized for congestive heart failure and 32 percent more likely to receive care for complication of diabetes.

17 Jun 2014

Text message improves glycemic control in high risk Latinos with type 2 diabetes

"Don't forget! Check blood sugar before and after physical activity." "Use small plates! Portions will look larger and you may feel more satisfied after eating." "Tick, tock. Take your medication at the same time every day!"

16 Jun 2014

Type 2 diabetes Patients who take metformin plus insulin at higher risk for heart disease, death

Patients with type 2 diabetes who take a combination of metformin plus insulin may be at higher risk for cardiovascular disease and death compared with those who take a combination of metformin plus sulfonylurea, according to a new study funded by the Agency for Healthcare Research and Quality that appears in the June 11 issue of JAMA.

11 Jun 2014

FDA accepts Pharmacyclics' IMBRUVICA sNDA for review

Pharmacyclics, Inc. today announced that the U.S. Food and Drug Administration has accepted for filing its supplemental New Drug Application (sNDA) to support the review of IMBRUVICA (ibrutinib) in the treatment of patients with chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) who have received at least one prior therapy for a full approval.

9 Jun 2014

Researchers recommend iron supplementation to women with heavy menstrual bleeding

A study by researchers from Finland found that diagnosis and treatment of anemia is important to improve quality of life among women with heavy periods.

9 Jun 2014

Research roundup: Funding for safety-net hospitals; insurance competition

Safety-net hospitals rely on disproportionate-share hospital (DSH) payments to help cover uncompensated care costs and underpayments by Medicaid

9 Jun 2014

Improved glycemic control can slow progression of ESRD in type 1 diabetic people

People with type 1 diabetes who have developed kidney complications can slow the progression of their complications by improving control of their glycemic (blood glucose) levels over the long term.

6 Jun 2014

Study results suggest growing support for patient-centered care management

Primary care doctors practicing in a model of coordinated, team-based care that leverages health information technology are more likely to give patients recommended preventive screening and appropriate tests than physicians working in other settings, according to research published today in the Annals of Internal Medicine.

4 Jun 2014

Findings could lead to treatments for blood disorders associated with iron deficiencies and overloads

A UCLA research team has discovered a new hormone called erythroferrone, which regulates the iron supply needed for red blood-cell production.

2 Jun 2014

Promedior reports positive preliminary data from PRM-151 Phase 2 trial for myelofibrosis

Promedior, Inc., today announced positive preliminary data from its Phase 2 trial of PRM-151, an anti-fibrotic immunotherapy, in patients with myelofibrosis which demonstrated biologic activity with improvements across clinically relevant measures, including bone marrow fibrosis, hemoglobin, platelets, spleen, and symptoms.

31 May 2014

Patients with diabetes mellitus have worse long-term outcomes following CABG surgery

Patients with diabetes mellitus have worse long-term outcomes and higher associated costs following coronary artery bypass grafting (CABG) surgery than patients without diabetes, according to a study in the June 2014 issue of The Annals of Thoracic Surgery.

29 May 2014

FDA approves Trimel’s Natesto nasal gel to treat adult males with low testosterone

Trimel Pharmaceuticals Corporation announced today that the United States Food and Drug Administration (FDA) has approved Natesto (testosterone), formerly CompleoTRT, the first and only testosterone nasal gel for replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone.

29 May 2014

Immucor's PreciseType HEA test receives FDA approval to predict blood compatibility

Immucor, Inc., a global leader in transfusion and transplantation diagnostics, announced that the U.S. Food and Drug Administration has granted approval for the company's PreciseType HEA test.

23 May 2014

Data from phase III trials supports safety, efficacy of linagliptin in treating T2D in African-American adults

Data from a retrospective pooled analysis of eight phase III trials (two 18-week and six 24-week) of linagliptin 5 mg once-daily, showed reductions from baseline A1c at 18 (eight trials) and 24 (six trials) weeks compared to placebo in African-American adults with type 2 diabetes (T2D),

16 May 2014

Hemoglobin News and Research

Adults with Type 2 diabetes achieve better blood glucose control after sleeve gastrectomy surgery

Soy protein supplements do not reduce testosterone levels in men with Type 2 diabetes

Researchers find possible biological reason why people with diabetes are prone to depression

Empagliflozin lowers blood pressure in patients with Type 2 diabetes and hypertension

Empagliflozin drug reduces blood pressure in patients with Type 2 diabetes, hypertension

Five specific tests commonly performed in anesthesiology may not be necessary

Six essential screening tests all men should receive during lifetime

Text message improves glycemic control in high risk Latinos with type 2 diabetes

Type 2 diabetes Patients who take metformin plus insulin at higher risk for heart disease, death

FDA accepts Pharmacyclics' IMBRUVICA sNDA for review

Researchers recommend iron supplementation to women with heavy menstrual bleeding

Research roundup: Funding for safety-net hospitals; insurance competition

Improved glycemic control can slow progression of ESRD in type 1 diabetic people

Study results suggest growing support for patient-centered care management

Findings could lead to treatments for blood disorders associated with iron deficiencies and overloads

Promedior reports positive preliminary data from PRM-151 Phase 2 trial for myelofibrosis

Patients with diabetes mellitus have worse long-term outcomes following CABG surgery

FDA approves Trimel’s Natesto nasal gel to treat adult males with low testosterone

Immucor's PreciseType HEA test receives FDA approval to predict blood compatibility

Data from phase III trials supports safety, efficacy of linagliptin in treating T2D in African-American adults

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News